GERMANTOWN, Md., May 10 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that Dr. Edward M. Rudnic, Advancis president and CEO, will deliver a corporate presentation on Tuesday, May 16, 2006, at 10:30 a.m. local time (4:30 a.m. Eastern Time).
The presentation will take place as part of the Rodman and Renshaw Third Annual Global Healthcare Conference at the Le Meridien Hotel in Monte Carlo, Monaco. Dr. Rudnic’s remarks will be available live on the Advancis web site, where they also will be archived for 30 days.
To access the presentation, log on to http://www.advancispharm.com and click on the Presentations option in the Investor Relations section. Please connect to the web site several minutes prior to the start of the live presentation to ensure adequate time for any software download that may be necessary.
About Advancis Pharmaceutical:
Advancis Pharmaceutical Corporation is a pharmaceutical company focused on the development and commercialization of pulsatile drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibiotics in front- loaded staccato bursts, or “pulses,” are killed more efficiently and effectively than those under standard treatment regimens. Based on this finding, Advancis has developed a proprietary, once-a-day pulsatile delivery technology called PULSYS. By examining the resistance patterns of bacteria and applying its delivery technologies, Advancis has the potential to redefine infectious disease therapy and significantly improve drug efficacy, shorten length of therapy, and reduce drug resistance versus currently available antibacterial products. For more on Advancis, please visit http://www.advancispharm.com.
Advancis Pharmaceutical Corporation
CONTACT: Robert Bannon of Advancis Pharmaceutical Corporation,+1-301-944-6710, ir@advancispharm.com
Web site: http://www.advancispharm.com/
